510(k) Report

510(k) · Cleared

Cleared

Distal Access Catheter

K231218510(k) TraditionalCleared Jan 19, 2024266-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Accumedical Beijing, Ltd. · QJP Catheter, Percutaneous, Neurovasculature

Cleared on Jan 19, 2024 as substantially equivalent to K161152 (Micro Therapeutics, Inc. d/b/a ev3 Neurovascular, 2016) after a 266-day review. Its family tree reaches back 2 generations to 2011.

Decided
Jan 19, 2024
Review
266 days
Class
Class II
Product code
QJP
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K110055 (2011). No later device cites it as a predicate yet.

  1. Root · 2 generations backK110055 Reverse Medical Reflex Guide CatheterReverse Medical Corporation · 2011
  2. 1 generation backK161152 Navien Intracranial Support CatheterMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2016
  3. This deviceK231218 Distal Access CatheterAccumedical Beijing, Ltd. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K110055Reverse Medical Reflex Guide CatheterReverse Medical Corporation2011—
−1K161152Navien Intracranial Support CatheterMicro Therapeutics, Inc. d/b/a ev3 Neurovascular2016—
0 (this device)K231218Distal Access CatheterAccumedical Beijing, Ltd.2024—
FIG. 1 — Lineage of K231218, 2011–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QJP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QJP device

  1. #1 K212838 Benchmark Intracranial Access Systemscore 16.9 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K161152Navien Intracranial Support Catheter
Summary page 5
…variations. The catheter is provided sterile, nonpyrogenic, and is intended for single use only. 7. Identification of the Predicate Device 510(k) Number: K161152 Device Name: Navien™ Intracranial Support Catheter…
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2016—

Also cleared against K161152: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 7.3 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K161152.

How does its category compare?

All QJP devices

QJP Catheter, Percutaneous, Neurovasculature: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · QJP

22so far in 2026, the most since 2007

2020: 92021: 122022: 142023: 142024: 182025: 142026 (partial year): 22
2007high 22 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QJP

116in 2025

2020: 72 days median2021: 139 days median2022: 206 days median2023: 184 days median2024: 188 days median2025: 116 days median2026 (partial year): 141 days median
2007high 206 (2022) · low 72 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QJP

1in 2024

2024: 1
2007high 1 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QJP

688in 2025

2020: 162021: 292022: 302023: 752024: 1302025: 688
2007high 688 (2025) · low 0 (2007)2025

MAUDE reports naming product code QJP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
2020972016
202112139029
202214206030
202314184075
2024181881130
2025141160688
2026221410—

What is it indicated for?

The Distal Access Catheter is indicated for the introduction of interventional devices into the peripheral and neurovasculature.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K231218: Distal Access Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K231218

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026